Alex W. Email & Phone Number

Tampa, Fl, Us

Jena, De

InflaRx is a German biotech company with a U.S. subsidiary that develops “pioneering anti-inflammatory therapeutics.” • Directed the daily operations of the U.S. subsidiary, including FP&A, human resources, and IT.• Managed the non-research related operations of the U.S subsidiary.

Proliant Health & Biologicals and Entera Health are part of the Lauridsen Group, Inc. (LGI). Entera Health promoted a prescription medical food to U.S. gastroenterologists and Proliant marketed bovine serum albumen worldwide. Proliant had approximately 75 employees and $15 million in annual revenues.• Directed the daily financial operations of both companies, including FP&A. (My daily job duties were the same as those described in my previous position with Entera Health.)• Led the acquisition of Boval BioSolutions and Desert Biologicals by Proliant in 2019.

Raleigh, Nc, Us

RedHill (RDHL) is a publicly traded “specialty biopharmaceutical company primarily focused on development and commercialization of clinical late-stage, proprietary drugs for the treatment of gastrointestinal diseases.” • Directed all trade and general commercial operations. Transitioned commercial operations from Entera Health to RedHill, including: (1) transitioning EnteraGam® to RedHill, and (2) establishing a trade channel at RedHill.• Developed strategic plans for product lines, including analyzing prescriber trends, prescription trends, and voucher performance.

Ankeny, Iowa, Us

At the time, the company was run as Entera Health, which promoted EnteraGam® to gastroenterologists. The company had approximately 50 employees and $12 million in annual revenues.Board of Directors• Prepared and presented quarterly financial reports to the board of directors.• Acted as a liaison between the commercial business team and the board of directors.• Created an outside board to advise the board of directors.Commercial Analytics• Negotiated managed care contracts with pharmacy benefit managers and managed care organizations.• Established sampling policies, incentive compensation plans, and expense guidelines.• Established territories and call patterns. Managed white space and vehicle fleets.Financial Planning and Analysis• Directed all daily FP&A operations, including accounts payable, accounts receivable, audits, budgets, and close outs.• Established a contract management system. Reviewed and approved all contracts.• Developed KPIs for the monthly reports presented to the advisory board, the board of directors, and the executive team.• Managed the finances of all research and development projects.Operations Management• Supervised state licensing processes. Managed the in-licensing of Atrantil® and the out-licensing of EnteraGam®.• Managed due diligence and strategic planning processes, including the integration of products.• Established and ran weekly “Top Line” meetings to discuss projects and allocate resources among departments.Supply Chain Management• Managed inventory, including tracking.• Managed all third-party logistics (3PL), including relationships with manufacturers.

Cary, North Carolina, Us

Cornerstone Therapeutics (CRTX) was “a specialty pharmaceutical company, engaged in the acquisition, development, and commercialization of branded and generic pharmaceuticals for the respiratory and related markets.”• Chairman of the Pricing Committee.• Provided financial summaries to executives.• Analyzed current and prospective company and product acquisitions. Made presentations to the board of directors.• Speaker at Financial Planning and Analysis (FP&A) conferences about object based financial modeling.Financial Planning and Analysis• Managed the entire budget and planning process.• Analyzed returns. Calculated returns on investments and tracked profitability (historical and projected).• Tracked monthly expense variance, weekly cash balance, and outstanding channel inventory.• Built dashboard with KPI’s that guided daily and weekly operating activities.• Implemented Whitebirch software to increase analysis capabilities, and the accuracy of the underlying data.• Projected cash flow. Worked with senior management to manage cash on hand.• Worked with marketing teams on naming, product life-cycle planning, and Key Opinion Leader (KOL) seminars.Compliance• Reviewed management discussion and analysis (MDA) for Form 10-K and Form 10-Q reporting.• Ensured compliance with GAAP and Sarbanes-Oxley (SOX). Managed monthly SOX procedure.

LipoScience developed proprietary diagnostic tests to address a broad range of metabolic and other diseases, including the risk of heart disease.• Created a new message, promotional material, and product positioning for the Clinical Analyzer test. Trained sales representatives on the message and product positioning.• Managed clinical symposia and round table discussions.• Developed a pricing model and forecast for a ‘First-in-Class’ medical device.• Helped develop strategic plans for Numera™ and the NMR LipoProfile test. Wrote the Numera™ marketing plan.• Implemented a new collection device with distribution partners.• Conducted primary market research for the target physician population.

• Established a performance tracking system that measured the profitability of managed care customers.• Evaluated the profitability of product lines and customers based on contract structure.• Calculated the impact of price increases and decreases to ensure profitability.• Designed systems that monitored rebate payments to ensure their accuracy. Recovered about $600,000 in rebates.• Established systems that improved the efficiency and profitability of the pricing and contracts department by increasing the number of metrics it measures.Associate Market Research Analyst• Evaluated the market potential of compounds and companies (foreign and domestic).• Forecasted all Mylan Bertek product sales. Changed the forecasting process to increase its accuracy.• Supported business development and marketing.

Wilmington, Nc, Us

AAIPharma Services Corp./Cambridge Major Laboratories, Inc., changed its name to Alcami in 2016. The two companies originally combined in 2013. Alcami is “a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries.” It offers “analytical testing and development services for active pharmaceutical ingredients (APIs) with oral solid and parenteral dose finished product capacity.”Market Research Analyst• Built forecasting models for Aquasol D, Brethine, and Azasan.• Researched pharmaceuticals and evaluated their market potential. Worked with senior executives to develop and implement U.S. and international market forecasting models.• Collated and summarized pharmaceutical data into research reports.• Primary source of market research data for product management, business development, and Japanese JV.Associate Product Manager (Darvon/Darvon-N)• Managed the promotion of Darvon and Darvocet-N.• Created and implemented a sales tracking and performance system.• Used internal research and development expertise to manage product life cycles, prolong brand life, and counteract generic cannibalization.• Developed and administered nationwide focus group research.Interim Product Manager (Brethine)• Wrote the marketing plan and implemented promotional strategies for Brethine. • Trained sales representatives and interns.Marketing Associate• Analyzed product performance for senior management, including providing advice about acquisition decisions.• Compiled databases and resources. Created a pharma market research department.

Mba, Business Administration

Bachelor Of Science - Bs, Business Administration